Two experimental paradigms were assessed: mice received M(IL4)s from C57/BL6 mice 33 days after the azoxymethane (AOM) or later in the progression of the CRC at 54 days after AOM treatment, and mice were humanely euthanized at day 113 (Figure 3A). Here, IL4 is linked to colorectal carcinoma.